2m 2m 2m 2m 2m 2m 2m
KEROS THERAP (KROS)
NASDAQ
$11.38+$0.12 (+1.07%)
Price as of Oct 02, 2026 5:49 PM EDT- $223.3MMarket Cap
- -27.73%1-Year Change
- BiotechnologyIndustry
KEROS THERAP (KROS)
$11.38+$0.12 (+1.07%)
Earnings Score
Valuation | KROS | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | KROS | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 3.46% | ||
12-Month Momentum | -27.55% | ||
3-Month Risk Adjusted Momentum | 15.41% | ||
12-Month Risk Adjusted Momentum | -55.66% |
True Yield
Valuation | KROS | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 4.53% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | KROS | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 13 |